U.S. Regulations & Administrative Codes

U.S. State Regulations & Administrative Codes

State regulations, or administrative laws, are rules adopted by the executive branch and agencies of each state. These regulations provide guidance on how to follow the laws (statutes) passed by the legislative bodies of each state.

These U.S. state regulations and administrative codes are made possible through a program established by Public.Resource.Org and were provided by Fastcase. They are edicts of government and are not subject to copyright.


U.S. Federal Register

Results 1 - 50 of 632,472
Reader Aids
Document Number: FR-2026-10-09-ReaderAids
Type: Reader Aids
Date: 2026-10-09
Fisheries of the Exclusive Economic Zone Off Alaska; Groundfish Reserves in the Bering Sea and Aleutian Islands Management Area
Document Number: C1-2026-20019
Type: Rule
Date: 2026-10-09
Agency: Department of Commerce, National Oceanic and Atmospheric Administration
Emergency Tax Relief on Diesel Fuel
Document Number: 2026-20855
Type: Executive Order
Date: 2026-10-09
Agency: Executive Office of the President
Sunshine Act Meeting
Document Number: 2026-20815
Type: Notice
Date: 2026-10-09
Agency: Consumer Product Safety Commission, Agencies and Commissions
Raisins Produced From Grapes Grown in California; Order Amending Marketing Order No. 989
Document Number: 2026-20792
Type: Rule
Date: 2026-10-09
Agency: Agricultural Marketing Service, Department of Agriculture
This final rule amends Marketing Order No. 989, which regulates the handling of raisins produced from grapes grown in California. The Department of Agriculture approves and adopts amendments proposed by the Raisin Administrative Committee (Committee) after due consideration of a public hearing record, and after California raisin producers voted in favor of such amendments in a referendum. This rule reduces the Committee membership size from 47 to 21, removes producer district representation and adds an unaffiliated producer member seat, eliminates the designated cooperative bargaining association member seat, and lowers quorum requirements from 25 to 14; removes the requirement for separate member and alternate member position nominations for independent and small cooperative producers; removes factor 4 and part of factor 5 for establishing marketing policy and adds language clarifying the quality of reconditioned raisins; and adds authority to accept voluntary contributions and language regarding ownership of intellectual property. In addition, this action makes necessary changes to the marketing order to conform to the amendments adopted.
Application of the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 to the Refunded Portion of Certain Federal Refundable Tax Credits; Hearing Cancellation
Document Number: 2026-20790
Type: Proposed Rule
Date: 2026-10-09
Agency: Internal Revenue Service, Department of Treasury, Department of the Treasury
This document cancels a public hearing on proposed regulations (REG-119882-25) published in the Federal Register on August 20, 2026. The proposed regulations would provide that the refunded portion of certain refundable Federal income tax credits available to individuals is a "Federal public benefit" under the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA).
Sunshine Act Meetings
Document Number: 2026-20788
Type: Notice
Date: 2026-10-09
Agency: Legal Services Corporation, Agencies and Commissions
Notice of Submission Deadline for Schedule Information for Chicago O'Hare International Airport, John F. Kennedy International Airport, Los Angeles International Airport, Newark Liberty International Airport, and San Francisco International Airport for the Summer 2027 Scheduling Season
Document Number: 2026-20784
Type: Notice
Date: 2026-10-09
Agency: Federal Aviation Administration, Department of Transportation
Under this notice, FAA announces the submission deadline of October 16, 2026, for Summer 2027 flight schedules at Chicago O'Hare International Airport (ORD), John F. Kennedy International Airport (JFK), Los Angeles International Airport (LAX), Newark Liberty International Airport (EWR), and San Francisco International Airport (SFO).
First Student, Inc.-Acquisition of Control-Autumn Transportation Inc. and Ambassador Wheelchair Services, Inc.
Document Number: 2026-20783
Type: Notice
Date: 2026-10-09
Agency: Surface Transportation Board, Department of Transportation
On August 4, 2026, First Student, Inc. (First Student), a noncarrier, filed an application seeking Board approval to acquire control of Autumn Transportation Inc. (Autumn) and Ambassador Wheelchair Services, Inc. (Ambassador) (collectively, the Target Carriers), through First Student's acquisition of all of the issued and outstanding capital stock of each entity. On September 23, 2026, EQT Infrastructure V Collect EUR SCSp and EQT Infrastructure V Collect USD SCSp, each a noncarrier acting by its manager EQT Fund Management S.[agrave] r.l., (collectively, EQT or the EQT Entities), filed a supplement to join First Student's application (EQT Supplement). First Student and EQT will be collectively referred to as Applicants. Also on September 23, 2026, First Student filed a supplement addressing the competitive conditions in the geographic area served by the Target Carriers (Competition Supplement). The Board is tentatively approving and authorizing the proposed acquisition of control. If no opposing comments are timely filed, this notice will be the final Board action.
Environmental Management Site-Specific Advisory Board, Oak Ridge
Document Number: 2026-20782
Type: Notice
Date: 2026-10-09
Agency: Department of Energy
This notice announces an in-person/virtual meeting of the Environmental Management Site-Specific Advisory Board (EM SSAB), Oak Ridge. The Federal Advisory Committee Act requires that public notice of this meeting be announced in the Federal Register.
Environmental Management Site-Specific Advisory Board, Savannah River Site
Document Number: 2026-20781
Type: Notice
Date: 2026-10-09
Agency: Department of Energy
This notice announces an in-person/livestreamed meeting of the Environmental Management Site-Specific Advisory Board (EM SSAB), Savannah River Site. The Federal Advisory Committee Act requires that public notice of this meeting be announced in the Federal Register.
Foreign-Trade Zone 16; Approval of Subzone Status; Yazaki North America, Inc.; Petoskey, Michigan
Document Number: 2026-20780
Type: Notice
Date: 2026-10-09
Agency: Department of Commerce, Foreign-Trade Zones Board
Passenger Vehicle and Light Truck Tires From Thailand: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Review; 2024-2025
Document Number: 2026-20779
Type: Notice
Date: 2026-10-09
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) preliminarily determines that passenger vehicle and light truck tires (PVLT) from Thailand were sold in the United States at less than normal value during the period of review (POR) July 1, 2024, through June 30, 2025. Interested parties are invited to comment on these preliminary results.
Certain Hot-Rolled Steel Flat Products From the Republic of Korea: Final Results of Countervailing Duty Administrative Review; 2023
Document Number: 2026-20778
Type: Notice
Date: 2026-10-09
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) determines Hyundai Steel Company (Hyundai Steel) and POSCO, producers/exporters of certain hot-rolled steel flat products (hot-rolled steel) from the Republic of Korea (Korea), received countervailable subsidies during the period of review (POR) January 1, 2023, through December 31, 2023.
Certain Paper Shopping Bags From Cambodia: Preliminary Results of Antidumping Duty Administrative Review; 2024-2025
Document Number: 2026-20777
Type: Notice
Date: 2026-10-09
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) preliminarily determines that certain paper shopping bags (paper shopping bags) from Cambodia were sold in the United States at less than normal value (NV) during the period of review (POR), January 3, 2024, through June 30, 2025. Interested parties are invited to comment on these preliminary results of review.
DPP Investors 2025 LP and DLA Piper LLP (US)
Document Number: 2026-20772
Type: Notice
Date: 2026-10-09
Agency: Securities and Exchange Commission, Agencies and Commissions
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2026-20771
Type: Notice
Date: 2026-10-09
Agency: Department of Health and Human Services, National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Document Number: 2026-20770
Type: Notice
Date: 2026-10-09
Agency: Department of Health and Human Services, National Institutes of Health
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZANVASTRO (Zilganersen)
Document Number: 2026-20769
Type: Notice
Date: 2026-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that ZANVASTRO (zilganersen), approved September 3, 2026, manufactured by Ionis Pharmaceuticals, Inc., meets the criteria for a priority review voucher.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biologics License Applications, Procedures and Requirements
Document Number: 2026-20768
Type: Notice
Date: 2026-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Notice of Availability of the Proposed Notice of Sale for Gulf of America Outer Continental Shelf Oil and Gas One Big Beautiful Bill Act Lease Sale 4
Document Number: 2026-20767
Type: Notice
Date: 2026-10-09
Agency: Department of the Interior, Bureau of Ocean Energy Management
The Bureau of Ocean Energy Management (BOEM) announces the availability of the Proposed Notice of Sale (NOS) for the Gulf of America (GOA) Outer Continental Shelf (OCS) Oil and Gas One Big Beautiful Bill Act (OBBBA) Lease Sale 4 (Lease Sale BBG4). BOEM is publishing this Notice pursuant to its regulatory authority under 30 CFR part 556. Pursuant to Section 19 of the OCS Lands Act, the Secretary of the Interior provides the Governors of affected States and the executive of any affected local government with the opportunity to review and comment on the Proposed NOS. The Proposed NOS describes the proposed size, timing, and location of the sale, including lease stipulations, terms and conditions, minimum bids, royalty rates, and rental rates which are required by Section 50102 of the OBBBA for this sale.
Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC
Document Number: 2026-20766
Type: Notice
Date: 2026-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for MONOFERRIC and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use
Document Number: 2026-20765
Type: Notice
Date: 2026-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Document Number: 2026-20764
Type: Notice
Date: 2026-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) has determined that LASIX (furosemide) oral solution, 10 milligrams (mg)/ milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.
National Environmental Policy Act Implementing Procedures: Wintertime Oil and Gas Exploration in the National Petroleum Reserve in Alaska Categorical Exclusion
Document Number: 2026-20763
Type: Notice
Date: 2026-10-09
Agency: Department of the Interior, Office of the Secretary
This notice announces a revision to the Department of the Interior (Department)'s National Environmental Policy Act (NEPA) procedures adding a new categorical exclusion (CE) for National Petroleum Reserve in Alaska (NPR-A) wintertime oil and gas exploration activities to the DOI Handbook of NEPA Implementing Procedures, Appendix 2: Bureau Categorical Exclusions.
Par Health USA LLC, U.S. Agent for PH Health Limited, et al.; Withdrawal of Approval of 37 Abbreviated New Drug Applications
Document Number: 2026-20762
Type: Notice
Date: 2026-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 37 abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Request for Comments on the Renewal of a Previously Approved Information Collection: War Risk Insurance, Applications, and Related Information
Document Number: 2026-20761
Type: Notice
Date: 2026-10-09
Agency: Maritime Administration, Department of Transportation
MARAD invites public comments on its intention to request Office of Management and Budget (OMB) approval to renew an information collection in accordance with the Paperwork Reduction Act of 1995. The proposed collection OMB 2133- 0011 (War Risk Insurance, Applications, and Related Information) is used to obtain war risk insurance from the U.S. Government, when such insurance is unavailable on reasonable terms from the commercial market. The program is mutually beneficial to the U.S. and the ship owner, in that it assures continued flow of essential U.S. trade and provides protection for the ship owner from loss by risks of war. MARAD is required to publish this notice in the Federal Register to obtain comments from the public and affected agencies.
Request for Comments on the Renewal of a Previously Approved Information Collection: Application and Reporting Elements for Participation in the Tanker Security Program
Document Number: 2026-20760
Type: Notice
Date: 2026-10-09
Agency: Maritime Administration, Department of Transportation
MARAD invites public comments on its intention to request Office of Management and Budget (OMB) approval to renew an information collection in accordance with the Paperwork Reduction Act of 1995. The proposed collection OMB 2133-0554 (Application and Reporting Elements for Participation in the Tanker Security Program) is used to evaluate the eligibility of applicants for participation in the Tanker Security Program (TSP). Since the last renewal, the application form for this collection is being updated to include minor clerical amendments regarding the authorizing statute and procedures for electronic submission. MARAD is required to publish this notice in the Federal Register to obtain comments from the public and affected agencies.
Amneal Pharmaceuticals of New York, LLC; Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams
Document Number: 2026-20758
Type: Notice
Date: 2026-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is withdrawing approval of abbreviated new drug application (ANDA) 208833 for Celecoxib capsules, 50 milligrams (mg), 100 mg, 200 mg, and 400 mg, held by Amneal Pharmaceuticals of New York, LLC, 50 Horseblock Rd., Brookhaven, NY 11719 (Amneal). Amneal requested withdrawal of approval of this application and has waived its opportunity for a hearing.
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
Document Number: 2026-20757
Type: Rule
Date: 2026-10-09
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/or the company that applied for the exemption no longer exists. These products will be removed from DEA's Table of Exempted Prescription Products and will no longer be considered exempt prescription products under the Controlled Substances Act. This action does not impact exempted prescription products with active NDC numbers.
Sunshine Act Meetings
Document Number: 2026-20755
Type: Notice
Date: 2026-10-09
Agency: Nuclear Regulatory Commission, Agencies and Commissions
Agency Information Collection Activities; Comment Request; Integrated Postsecondary Education Data System (IPEDS) 2026-27 Through 2028-29
Document Number: 2026-20754
Type: Notice
Date: 2026-10-09
Agency: Department of Education
In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing a revision of a currently approved information collection request (ICR).
Senior Executive Service Performance Review Board Membership
Document Number: 2026-20753
Type: Notice
Date: 2026-10-09
Agency: Council of the Inspectors General on Integrity and Efficiency
Certain Hydrodermabrasion Systems and Components Thereof; Notice of Vacatur of the Commission's Final Determination and Mootness of the Investigation by the Federal Circuit Due to Patent Expiration
Document Number: 2026-20752
Type: Notice
Date: 2026-10-09
Agency: International Trade Commission, Agencies and Commissions
Notice is hereby given that the U.S. International Trade Commission's ("Commission") final determination in the above- captioned investigation has been vacated by the U.S. Court of Appeals for the Federal Circuit ("Federal Circuit") and the investigation is terminated as moot as ordered by the Federal Circuit. The investigation was previously terminated on March 23, 2026.
Alexandra R. Lovec, A.P.R.N.; Decision and Order
Document Number: 2026-20751
Type: Notice
Date: 2026-10-09
Agency: Drug Enforcement Administration, Department of Justice
L Krenk DBA Maui Clinic Pharmacy; Decision and Order
Document Number: 2026-20750
Type: Notice
Date: 2026-10-09
Agency: Drug Enforcement Administration, Department of Justice
Vladimir Romaniv, P.A.; Decision and Order
Document Number: 2026-20749
Type: Notice
Date: 2026-10-09
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
Document Number: 2026-20748
Type: Rule
Date: 2026-10-09
Agency: Drug Enforcement Administration, Department of Justice
On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that specifically noted in the summary that the control of O-desmethyltramadol included its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, however inadvertently omitted the correct language that should have been included. This document corrects that error, adding the correct language.
Combined Notice Of Filings
Document Number: 2026-20747
Type: Notice
Date: 2026-10-09
Agency: Department of Energy, Federal Energy Regulatory Commission
Records Governing Off-the-Record Communications; Public Notice
Document Number: 2026-20746
Type: Notice
Date: 2026-10-09
Agency: Department of Energy, Federal Energy Regulatory Commission
Combined Notice of Filings #1
Document Number: 2026-20745
Type: Notice
Date: 2026-10-09
Agency: Department of Energy, Federal Energy Regulatory Commission
Combined Notice of Filings #2
Document Number: 2026-20744
Type: Notice
Date: 2026-10-09
Agency: Department of Energy, Federal Energy Regulatory Commission
Agency Information Collection Activities; Comment Request on Consent To Extend the Time To Assess Tax Under Section 367-Gain Recognition Agreement
Document Number: 2026-20743
Type: Notice
Date: 2026-10-09
Agency: Internal Revenue Service, Department of Treasury, Department of the Treasury
In accordance with the Paperwork Reduction Act of 1995, the IRS is inviting comments on the information collection request outlined in this notice.
Fermi America LLC (dba Fermi America); Project Matador Advanced Energy and Intelligence Campus AP1000 Units 1-4; Project Matador Nuclear Units 1-4; Draft Environmental Impact Statement
Document Number: 2026-20742
Type: Notice
Date: 2026-10-09
Agency: Nuclear Regulatory Commission, Agencies and Commissions
The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment a draft Environmental Impact Statement (EIS). The draft EIS is in response to a Combined License (COL) application submitted by Fermi America for the proposed construction and operation of four AP1000 advanced passive pressurized-water reactorsdesignated as Project Matador Nuclear Units 1-4 (PMN Units 1-4). PMN Units 1-4 would be located at the Project Matador Advanced Energy and Intelligence Campus (Project Matador campus). The draft EIS evaluates the environmental impacts of the proposed action of issuing a COL that would allow the construction of PMN Units 1-4, as well as the environmental impacts of the no-action alternative (i.e., denying the COL application).